$400.68
At close: May 1 EDT
$400.28
-0.40-0.10%
Pre-Market: 7:58 PM EDT
Comments
Loading...
UnitedHealth Group Analyst Ratings and Price Targets | NYSE:UNH | Benzinga
UnitedHealth Group Inc has a consensus price target of $595.48 based on the ratings of 28 analysts. The high is $700 issued by Cantor Fitzgerald on January 17, 2025. The low is $460 issued by HSBC on April 4, 2024. The 3 most-recent analyst ratings were released by Baird, Barclays, and JP Morgan on April 29, 2025, April 24, 2025, and April 24, 2025, respectively. With an average price target of $516 between Baird, Barclays, and JP Morgan, there's an implied 28.91% upside for UnitedHealth Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Baird
Barclays
JP Morgan
RBC Capital
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for UnitedHealth Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/29/2025 | Buy Now | 27.41% | Baird | Michael Ha48% | $640 → $510 | Maintains | Outperform | Get Alert |
| 04/24/2025 | Buy Now | 28.16% | Barclays | Andrew Mok56% | $560 → $513 | Maintains | Overweight | Get Alert |
| 04/24/2025 | Buy Now | 31.16% | JP Morgan | Lisa Gill57% | $652 → $525 | Maintains | Overweight | Get Alert |
| 04/23/2025 | Buy Now | 31.16% | RBC Capital | Ben Hendrix60% | $655 → $525 | Maintains | Outperform | Get Alert |
| 04/22/2025 | Buy Now | — | HSBC | Sidharth Sahoo53% | — | Downgrade | Buy → Hold | Get Alert |
| 04/22/2025 | Buy Now | 40.65% | Morgan Stanley | Ricky Goldwasser79% | $664 → $563 | Maintains | Overweight | Get Alert |
| 04/21/2025 | Buy Now | — | Argus Research | David Toung71% | — | Downgrade | Buy → Hold | Get Alert |
| 04/21/2025 | Buy Now | 44.9% | Truist Securities | David Macdonald65% | $660 → $580 | Maintains | Buy | Get Alert |
| 04/21/2025 | Buy Now | 39.9% | Barclays | Andrew Mok56% | $642 → $560 | Maintains | Overweight | Get Alert |
| 04/21/2025 | Buy Now | 43.65% | Keybanc | Tim Rezvan49% | $650 → $575 | Maintains | Overweight | Get Alert |
| 04/21/2025 | Buy Now | 34.91% | Raymond James | John Ransom76% | $635 → $540 | Reiterates | Strong Buy → Strong Buy | Get Alert |
| 04/21/2025 | Buy Now | 49.9% | Oppenheimer | Michael Wiederhorn61% | $640 → $600 | Maintains | Outperform | Get Alert |
| 04/11/2025 | Buy Now | 64.88% | Truist Securities | David Macdonald65% | $610 → $660 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | 62.39% | Mizuho | Ann Hynes85% | $600 → $650 | Maintains | Outperform | Get Alert |
| 01/28/2025 | Buy Now | 64.88% | Wells Fargo | Stephen Baxter54% | $694 → $660 | Maintains | Overweight | Get Alert |
| 01/17/2025 | Buy Now | 60.39% | Barclays | Andrew Mok56% | $655 → $642 | Maintains | Overweight | Get Alert |
| 01/17/2025 | Buy Now | 62.39% | Keybanc | Steve Barger72% | $650 → $650 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2025 | Buy Now | 74.88% | Cantor Fitzgerald | Sarah James51% | $700 → $700 | Reiterates | Overweight → Overweight | Get Alert |
| 01/06/2025 | Buy Now | 52.39% | Truist Securities | David Macdonald65% | $625 → $610 | Maintains | Buy | Get Alert |
| 01/02/2025 | Buy Now | 49.9% | Piper Sandler | Jessica Tassan38% | $605 → $600 | Maintains | Overweight | Get Alert |
| 12/06/2024 | Buy Now | 59.89% | Oppenheimer | Michael Wiederhorn61% | $610 → $640 | Maintains | Outperform | Get Alert |
| 12/05/2024 | Buy Now | 68.63% | Stephens & Co. | Scott Fidel70% | $605 → $675 | Maintains | Overweight | Get Alert |
| 12/03/2024 | Buy Now | 56.14% | Deutsche Bank | George Hill62% | $595 → $625 | Maintains | Buy | Get Alert |
| 11/27/2024 | Buy Now | 63.64% | Barclays | Andrew Mok56% | $603 → $655 | Maintains | Overweight | Get Alert |
| 10/22/2024 | Buy Now | 50.64% | Barclays | Andrew Mok56% | $604 → $603 | Maintains | Overweight | Get Alert |
| 10/18/2024 | Buy Now | 52.14% | TD Cowen | Gary Taylor60% | $601 → $609 | Maintains | Buy | Get Alert |
| 10/16/2024 | Buy Now | 62.39% | UBS | Kevin Caliendo71% | $680 → $650 | Maintains | Buy | Get Alert |
| 10/16/2024 | Buy Now | 51.14% | Stephens & Co. | Scott Fidel70% | $632 → $605 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 60.89% | Cantor Fitzgerald | Sarah James51% | $591 → $644 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 56.14% | Truist Securities | David Macdonald65% | $640 → $625 | Reiterates | Buy → Buy | Get Alert |
| 10/16/2024 | Buy Now | 48.65% | RBC Capital | Ben Hendrix60% | $615 → $595 | Maintains | Outperform | Get Alert |
| 10/16/2024 | Buy Now | 62.39% | Keybanc | Matthew Gillmor65% | $675 → $650 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 52.39% | Morgan Stanley | Ricky Goldwasser79% | $615 → $610 | Maintains | Overweight | Get Alert |
| 10/16/2024 | Buy Now | 62.39% | B of A Securities | Kevin Fischbeck68% | $675 → $650 | Maintains | Buy | Get Alert |
| 10/11/2024 | Buy Now | 68.63% | Keybanc | Matthew Gillmor65% | → $675 | Initiates | → Overweight | Get Alert |
| 10/01/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 09/20/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 09/10/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 08/19/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 07/23/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 07/18/2024 | Buy Now | 69.88% | UBS | Kevin Caliendo71% | $640 → $680 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 49.9% | Argus Research | David Toung71% | $570 → $600 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 50.14% | TD Cowen | Gary Taylor60% | $546 → $601 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 50.89% | Barclays | Andrew Mok56% | $560 → $604 | Maintains | Overweight | Get Alert |
| 07/17/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 07/17/2024 | Buy Now | 57.39% | Wells Fargo | Stephen Baxter54% | $525 → $630 | Maintains | Overweight | Get Alert |
| 07/17/2024 | Buy Now | 59.89% | Truist Securities | David Macdonald65% | $600 → $640 | Maintains | Buy | Get Alert |
| 07/17/2024 | Buy Now | 53.64% | RBC Capital | Ben Hendrix60% | $555 → $615 | Maintains | Outperform | Get Alert |
| 07/17/2024 | Buy Now | 61.64% | Jefferies | David Windley74% | $481 → $647 | Upgrade | Hold → Buy | Get Alert |
| 07/17/2024 | Buy Now | 59.89% | Baird | Michael Ha48% | $597 → $640 | Maintains | Outperform | Get Alert |
| 07/17/2024 | Buy Now | 53.64% | Morgan Stanley | Ricky Goldwasser79% | $595 → $615 | Maintains | Overweight | Get Alert |
| 07/09/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 05/30/2024 | Buy Now | 39.65% | JP Morgan | Lisa Gill57% | $546 → $559 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 49.15% | Baird | Michael Ha48% | → $597 | Initiates | → Outperform | Get Alert |
| 04/19/2024 | Buy Now | 40.4% | Deutsche Bank | George Hill62% | $545 → $562 | Maintains | Buy | Get Alert |
| 04/17/2024 | Buy Now | 49.9% | Truist Securities | David Macdonald65% | → $600 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2024 | Buy Now | 38.65% | RBC Capital | Ben Hendrix60% | $596 → $555 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 39.9% | Barclays | Andrew Mok56% | $534 → $560 | Maintains | Overweight | Get Alert |
| 04/17/2024 | Buy Now | 42.65% | Piper Sandler | Jessica Tassan38% | $566 → $571 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | 36.4% | TD Cowen | Gary Taylor60% | $607 → $546 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | 31.16% | Wells Fargo | Stephen Baxter54% | $600 → $525 | Maintains | Overweight | Get Alert |
| 04/05/2024 | Buy Now | 45.9% | Morgan Stanley | Ricky Goldwasser79% | $618 → $584 | Maintains | Overweight | Get Alert |
| 04/04/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 04/04/2024 | Buy Now | 14.92% | HSBC | Rajesh Kumar60% | → $460 | Upgrade | Reduce → Hold | Get Alert |
| 03/13/2024 | Buy Now | — | Erste Group | Hans Engel60% | — | Downgrade | Buy → Hold | Get Alert |
| 03/07/2024 | Buy Now | 68.63% | B of A Securities | Kevin Fischbeck68% | $675 → $675 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | 37.65% | Barclays | Andrew Mok56% | → $551 | Initiates | → Overweight | Get Alert |
| 02/29/2024 | Buy Now | 48.9% | RBC Capital | Ben Hendrix60% | $596 → $596 | Reiterates | Outperform → Outperform | Get Alert |
| 02/08/2024 | Buy Now | 51.14% | Stephens & Co. | Scott Fidel70% | $605 → $605 | Reiterates | Overweight → Overweight | Get Alert |
| 01/19/2024 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | $591 → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 01/17/2024 | Buy Now | 52.39% | Oppenheimer | Michael Wiederhorn61% | → $610 | Reiterates | Outperform → Outperform | Get Alert |
| 01/17/2024 | Buy Now | 45.15% | Piper Sandler | Jessica Tassan38% | $584 → $581 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | 51.14% | Stephens & Co. | Scott Fidel70% | $615 → $605 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | 48.9% | RBC Capital | Ben Hendrix60% | $596 → $596 | Reiterates | Outperform → Outperform | Get Alert |
| 12/18/2023 | Buy Now | 19.92% | HSBC | Rajesh Kumar60% | $550 → $480 | Downgrade | Hold → Reduce | Get Alert |
| 12/13/2023 | Buy Now | 46.15% | Stephens & Co. | Scott Fidel70% | $585 → $585 | Reiterates | Overweight → Overweight | Get Alert |
| 11/30/2023 | Buy Now | 52.39% | Truist Securities | David Macdonald65% | → $610 | Reiterates | Buy → Buy | Get Alert |
| 11/30/2023 | Buy Now | 48.9% | RBC Capital | Ben Hendrix60% | → $596 | Reiterates | Outperform → Outperform | Get Alert |
| 11/30/2023 | Buy Now | 46.15% | Stephens & Co. | Scott Fidel70% | → $585 | Reiterates | Overweight → Overweight | Get Alert |
| 11/21/2023 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | Buy Now | 25.66% | Jefferies | David Windley74% | $565 → $503 | Maintains | Hold | Get Alert |
| 10/23/2023 | Buy Now | 44.65% | Morgan Stanley | Ricky Goldwasser79% | $587 → $579 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 48.9% | RBC Capital | Ben Hendrix60% | $572 → $596 | Maintains | Outperform | Get Alert |
| 10/16/2023 | Buy Now | 45.9% | Piper Sandler | Jessica Tassan38% | $580 → $584 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 59.89% | UBS | Kevin Caliendo71% | → $640 | Upgrade | Neutral → Buy | Get Alert |
| 10/09/2023 | Buy Now | 32.66% | Jefferies | David Windley74% | $529 → $531 | Maintains | Hold | Get Alert |
| 09/14/2023 | Buy Now | 47.65% | Cantor Fitzgerald | Sarah James51% | → $591 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2023 | Buy Now | 34.91% | HSBC | Morten Herholdt39% | → $540 | Initiates | → Hold | Get Alert |
| 08/11/2023 | Buy Now | 39.9% | Stephens & Co. | Scott Fidel70% | → $560 | Reiterates | Overweight → Overweight | Get Alert |
| 07/19/2023 | Buy Now | 29.91% | UBS | Kevin Caliendo71% | $510 → $520 | Maintains | Neutral | Get Alert |
| 07/18/2023 | Buy Now | 50.64% | Bernstein | Lance Wilkes62% | $595 → $603 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/17/2023 | Buy Now | 38.65% | Deutsche Bank | George Hill62% | $564 → $555 | Maintains | Buy | Get Alert |
| 07/17/2023 | Buy Now | 42.9% | RBC Capital | Ben Hendrix60% | $592 → $572 | Maintains | Outperform | Get Alert |
| 07/17/2023 | Buy Now | 52.39% | Oppenheimer | Michael Wiederhorn61% | → $610 | Reiterates | Outperform → Outperform | Get Alert |
| 07/14/2023 | Buy Now | 62.39% | B of A Securities | Kevin Fischbeck68% | $650 → $650 | Maintains | Buy | Get Alert |
| 07/14/2023 | Buy Now | 46.65% | Morgan Stanley | Erin Wright75% | $587 → $587 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | 27.41% | UBS | Kevin Caliendo71% | $550 → $510 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for UnitedHealth Group (UNH) stock?
The latest price target for UnitedHealth Group (NYSE:UNH) was reported by Baird on April 29, 2025. The analyst firm set a price target for $510.00 expecting UNH to rise to within 12 months (a possible 27.41% upside). 56 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for UnitedHealth Group (UNH)?
The latest analyst rating for UnitedHealth Group (NYSE:UNH) was provided by Baird, and UnitedHealth Group maintained their outperform rating.
When was the last upgrade for UnitedHealth Group (UNH)?
The last upgrade for UnitedHealth Group Inc happened on July 17, 2024 when Jefferies raised their price target to $647. Jefferies previously had a hold for UnitedHealth Group Inc.
When was the last downgrade for UnitedHealth Group (UNH)?
The last downgrade for UnitedHealth Group Inc happened on April 22, 2025 when HSBC changed their price target from N/A to N/A for UnitedHealth Group Inc.
When is the next analyst rating going to be posted or updated for UnitedHealth Group (UNH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of UnitedHealth Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for UnitedHealth Group was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.
Is the Analyst Rating UnitedHealth Group (UNH) correct?
While ratings are subjective and will change, the latest UnitedHealth Group (UNH) rating was a maintained with a price target of $640.00 to $510.00. The current price UnitedHealth Group (UNH) is trading at is $400.28, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
